Search Results - person:"Cassiman, David"

Fostering practice-oriented and use-inspired science in biomedical research

Anckaert, Paul-Emmanuel; Cassiman, David; Cassiman, Bruno - In: Research policy : policy, management and economic … 49 (2020) 2, pp. 1-14

Persistent link: https://www.econbiz.de/10012430291

Cost-Effectiveness Assessment of Orphan Drugs

Simoens, Steven; Picavet, Eline; Dooms, Marc; Cassiman, … - In: Applied Health Economics and Health Policy 11 (2013) 1, pp. 1-3

Persistent link: https://www.econbiz.de/10010848792

Evaluating and improving orphan drug regulations in Europe: A Delphi policy study

Picavet, Eline; Cassiman, David; Simoens, Steven - In: Health Policy 108 (2012) 1, pp. 1-9

To encourage the development of orphan drugs, the European Union has implemented specific policies in 2000. However, the political, social, scientific and economic context has changed since the implementation of these policies. For that reason, the aim of this article is to evaluate orphan drug...

Persistent link: https://www.econbiz.de/10010588184

Drugs for Rare Diseases: Influence of Orphan Designation Status on Price

Picavet, Eline; Dooms, Marc; Cassiman, David; Simoens, … - In: Applied Health Economics and Health Policy 9 (2011) 4, pp. 275-279

Persistent link: https://www.econbiz.de/10010614274

Drugs for rare diseases: Influence of orphan designation status on price

Picavet, Eline; Dooms, Marc; Cassiman, David; Simoens, … - In: Applied Health Economics and Health Policy 9 (2011) 4, pp. 275-279

The literature indicates that the expenditure on orphan drugs will be increasing over the coming years. The market for orphan drugs has inherent market characteristics that sometimes result in high prices. The aim of this study was to analyse whether awarding orphan designation status has an...

Persistent link: https://www.econbiz.de/10011000788